Investors Boost Barr Pharma

The generic drugmaker's shares climbed Wednesday after it announced earnings that beat analyst expectations

Barr Pharmaceuticals (BRL) shares jolted higher after the generic drug maker reported first-quarter earnings per share that were better than expected and kept its guidance intact for the year.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.